Sign In | Join Free | My
Wuhan uni-pharma bio-tech co.,ltd
Wuhan Uni-pharma Bio-tech Co.,Ltd
Home > Pharmaceutical Capsules >

Finished Medicie Pharmaceutical Capsules Lincomycin Hydrochloride Capsules USP Bacteriostatic Antimicrobial

Wuhan uni-pharma bio-tech co.,ltd
Wuhan uni-pharma bio-tech co.,ltd
Province/State: Hubei
Country/Region: China
Tel: 86-27-82316816

Finished Medicie Pharmaceutical Capsules Lincomycin Hydrochloride Capsules USP Bacteriostatic Antimicrobial

Brand Name : UNIPHAR
Model Number : 500MG
Certification : GMP
Place of Origin : CHINA
MOQ : 50000 Boxes
Price : Negotiation
Supply Ability : 500000 Boxes per month
Delivery Time : 45-50 days
Packaging Details : 12 Capsules/ Color box
Efficacy : Treatment of osteomyelitis
Pacage : 12 Capsules/Color box
Character : White crystalline powder
Storage instruction : At controlled room temperature (15-30℃)
English alias : Jiemycin
Standard : USP
Expiration Date : 3 Years
Ways : Oral
Contact Now

Good Quality GMP Certification Lincomycin Hydrochloride Capsules USP Bacteriostatic Antimicrobial

Each capsule contains:

Lincomycin hydrochloride monohydrate equivalent to Lincomycin 500mg.

Caution: To be dispensed only by or on the prescription of a physician.

Each capsule contains:

Lincomycin500mgActive ingredientsB.P.2000
hydroxypropyl cellulose25mgExcipients
magnesium stearate20mgExcipients
Sodium Starch10mgExcipients

Recommended clinical use.

Lincomycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular blocking agents. Therefore it should be used with caution in patients receiving such agents.

Lincomycin should be administered with caution in atopic individuals.

Patients with very severe renal disease and/or very severe hepatic disease accompanied by severe metabolic aberrations should be dosed with caution, and serum lincomycin levels monitored during high-dose therapy.

1. Serious infections: 30mg/kg/day divided into 3 or 4 equal doses

2. More severe infections: 60mg/kg/day divided into 3 or 4 equal doses.

When therapy with lincomycin is required in individuals with severe impairment of renal function, an appropriate dose is 25 to 30% of that recommended for patients with normally functioning kidneys. In cases of beta-hemofytic streptococcal infections, treatment should be continued for at least 10 days.

For optimal absorption it is recommended that nothing be given by mouth for a period of one to two hours before and after oral administration of lincomycin.


Severe cardiopulmonary reactions have occurred when this drug has been given at greater than the recommended concentration and rate.


This product is suitable for sensitive Staphylococcus, Streptococcus, Streptococcus pneumoniae and anaerobic bacteria caused by respiratory infections.

Skin and soft tissue infection in female genital tract infection and pelvic infection and intra-abdominal infection, the latter two kinds of diseases according to the FDA alone or with other combined application of antibiotics in addition to.

Indications in patients with application of penicillin, such as patients with penicillin allergy to penicillin or not.

This product can be used as alternative medicine.

Lincomycin has found to be effective in the treatment of infections caused by susceptible trains of gram-positive aerobes such as streptococci, pneumococci and staphyiocci. And also in the following infections:

1. Upper respiratory infections including tonsillitis, pharyngitis, otitismedia, sinusitis, scarlet fever and as adjuvant therapy of diphtheria.

2. Lower respiratory infections including acute bronchitis and pneumonia.

3. Skin & soft tissue infections including celiulitis, furuncles, abscesses, impetigo, acne and wound infections.

4. Bone & joint infections including osteomyelitis and septic arthritis.

5. Senpticemia and endocarditis and bacillary dysentery.


Contraindicated in patients haveing known sensitivity towards lincomycin or clindamycin. Also contraindicated in lactating mothers.

LINCOMYCIN is a incosamices antibiotic with the primarily bacteriostatic action against gram-postive aerobes and a wide range of anaerobic bacteria , binds to 50s subunit of the bacterial ribosome similarly to macrolide and inhibites the early stages of protein synthesis.

The action of LINCOMYCINE is predominantly bacteriostatic although high concentration may be slowly bactericidal against sensitivie strains.

Product Tags:

organic gelatin capsules


medical capsules

China Customized Inflatable Bumper Ball Game Bubble Adult Grass CE supplier

Finished Medicie Pharmaceutical Capsules Lincomycin Hydrochloride Capsules USP Bacteriostatic Antimicrobial Images

Inquiry Cart 0
Send your message to this supplier
Enter your email please.
To: Wuhan uni-pharma bio-tech co.,ltd
Characters Remaining: (0/3000)
Inquiry Cart 0